Ketoisdin (Ketoconazole)

Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesizing ergosterol, a key component of the fungal cell membrane. Disruption of ergosterol production weakens the membrane, leading to impaired fungal growth and cell death.

The dosing regimen for Ketoisdin is determined by the prescribing healthcare professional based on the specific product formulation and the severity of the infection. Patients should follow the prescriber’s instructions and the product label.

Safety data for ketoconazole use during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Ketoisdin.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ketoisdin delivers ketoconazole locally to the vaginal area, offering targeted therapy with minimal systemic exposure. Compared with oral azoles, it may reduce systemic side effects while providing effective eradication of Candida species. Choice of therapy depends on infection severity, patient preference, and clinician judgment.

Store Ketoisdin at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain its stability and efficacy.

Ketoisdin is applied intravaginally according to the prescriber’s instructions, typically using a pre‑filled applicator. The patient should lie down for a few minutes after application to allow proper distribution of the medication.

Serious risks, though rare, include severe allergic reactions such as rash, hives, or swelling, and rare systemic effects like hepatotoxicity. Patients should seek immediate medical attention if they experience signs of a serious reaction.

Ketoisdin should be avoided in individuals with known hypersensitivity to ketoconazole or any component of the formulation. It is also not recommended for patients with severe liver disease or those who are currently using other topical azole antifungals without medical guidance.